TY - JOUR
T1 - Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency
T2 - Data From the USIDNET Registry
AU - USIDNET Consortium
AU - Durkee-Shock, Jessica
AU - Zhang, Anqing
AU - Liang, Hua
AU - Wright, Hannah
AU - Magnusson, Julieann
AU - Garabedian, Elizabeth
AU - Marsh, Rebecca A.
AU - Sullivan, Kathleen E.
AU - Keller, Michael D.
AU - Puck, Jennifer
AU - Secord, Elizabeth
AU - Akhter, Javeed
AU - Pozos, Tamara
AU - Fuleihan, Ramsay
AU - Chen, Karin
AU - Buckley, Rebecca
AU - Patel, Niraj
AU - Suez, Daniel
AU - Cooper, Megan
AU - Butte, Manish
AU - Bonilla, Francisco
AU - Walkovich, Kelly
AU - Haddad, Elie
AU - Cunningham-Rundles, Charlotte
AU - Kleiner, Gary
AU - Chong, Hey
AU - Ballas, Zuhair
AU - Uygungil, Burcin
AU - Hernandez-Trujillo, Vivian
AU - Secord, Elizabeth A.
AU - Hartog, Nicholas
AU - Dorsey, Morna
AU - Shapiro, Ralph
AU - Schuval, Susan
AU - Notarangelo, Luigi
AU - Routes, John
AU - Knight, Adina
AU - Bennett, Nicholas
AU - Khan, Fatima
AU - Walter, Jolan
AU - Seroogy, Christine
AU - Ochs, Hans
AU - Haines, Kathleen
AU - Muskat, Mica
AU - Costa Reis, Patricia
AU - Cheng, Laurence
N1 - Publisher Copyright:
© 2022
PY - 2022/5
Y1 - 2022/5
N2 - Background: Optimal management of patients with combined immunodeficiency, especially pertaining to hematopoietic stem cell transplantation (HSCT), remains unclear. Objective: To identify factors influencing HSCT and mortality in the population with combined immunodeficiency in North America. Methods: We identified 337 participants in the United States Immunodeficiency Network database with diverse forms of combined immunodeficiency and their characteristics, including demographic characteristics, laboratory values, infectious history, comorbidities, and treatment strategies. Univariate analysis was performed using logistic regression, whereas multivariate analysis was performed using multiple Cox proportional hazards. Results: On univariate analysis, disseminated invasive viral infections and variants in STAT3, GATA2, and, DOCK8 were associated with increased odds of HSCT. Mucocutaneous fungal infections and variants in STAT3 were associated with increased odds of survival, whereas disseminated/invasive fungal infections, disseminated/invasive viral infections, and parasitic infections were associated with decreased odds of survival. On multiple variable Cox proportional hazards analysis, variants in ZAP70, nonspecific bacterial, and disseminated/invasive viral infections were associated with increased hazards of transplantation, whereas variants in multiple genes (RMRP, NEMO, DOCK8, CD40L, and CARD9), disseminated/invasive viral infections, autoimmune disease, and higher absolute lymphocyte count were associated with increased hazards of death. Importantly, demographic characteristics, basic lymphocyte subset counts, and absence of genetic diagnosis were not associated with HSCT or mortality. Conclusions: We determined that specific genetic diagnoses and infection burden impacts the decision to undergo HSCT in this cohort. In addition, certain genetic diagnoses and invasive viral infections carry an increased risk of mortality.
AB - Background: Optimal management of patients with combined immunodeficiency, especially pertaining to hematopoietic stem cell transplantation (HSCT), remains unclear. Objective: To identify factors influencing HSCT and mortality in the population with combined immunodeficiency in North America. Methods: We identified 337 participants in the United States Immunodeficiency Network database with diverse forms of combined immunodeficiency and their characteristics, including demographic characteristics, laboratory values, infectious history, comorbidities, and treatment strategies. Univariate analysis was performed using logistic regression, whereas multivariate analysis was performed using multiple Cox proportional hazards. Results: On univariate analysis, disseminated invasive viral infections and variants in STAT3, GATA2, and, DOCK8 were associated with increased odds of HSCT. Mucocutaneous fungal infections and variants in STAT3 were associated with increased odds of survival, whereas disseminated/invasive fungal infections, disseminated/invasive viral infections, and parasitic infections were associated with decreased odds of survival. On multiple variable Cox proportional hazards analysis, variants in ZAP70, nonspecific bacterial, and disseminated/invasive viral infections were associated with increased hazards of transplantation, whereas variants in multiple genes (RMRP, NEMO, DOCK8, CD40L, and CARD9), disseminated/invasive viral infections, autoimmune disease, and higher absolute lymphocyte count were associated with increased hazards of death. Importantly, demographic characteristics, basic lymphocyte subset counts, and absence of genetic diagnosis were not associated with HSCT or mortality. Conclusions: We determined that specific genetic diagnoses and infection burden impacts the decision to undergo HSCT in this cohort. In addition, certain genetic diagnoses and invasive viral infections carry an increased risk of mortality.
KW - Combined immunodeficiency
KW - Hematopoietic stem cell transplantation
KW - Mortality
KW - USIDNET
UR - http://www.scopus.com/inward/record.url?scp=85127353918&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2022.01.042
DO - 10.1016/j.jaip.2022.01.042
M3 - Article
C2 - 35172220
AN - SCOPUS:85127353918
SN - 2213-2198
VL - 10
SP - 1334-1341.e6
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 5
ER -